Search Within

Department of Medicine

Formats
  1. Journal Article (19596)
  2. Meeting Abstract (16046)
  3. Review (1153)
  4. Book Section (934)
  5. Editorial (610)
  6. Research Letter (314)
  7. Conference Paper (301)
  8. Guidelines (295)
  9. Correspondence (236)
  10. Miscellaneous (90)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22327)
  2. Hematologic Malignancies, Division of (13280)
  3. Center for Hematologic Malignancies (11063)
  4. GSK Faculty (10648)
  5. Survivorship Research (9336)
  6. Division of Subspecialty Medicine (7544)

More Groups

People
  1. Robert Motzer (1248)
  2. Howard Scher (1132)
  3. Sergio Giralt (1069)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (905)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1085)
  2. 2024 (2291)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3722)
  3. Annals of Oncology (1398)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (902)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6458)
  2. Elsevier Inc. (4216)
  3. American Society of Hematology (4003)
  4. American Association for Cancer Research (2896)
  5. Oxford University Press (2287)
  6. Nature Publishing Group (2111)

More Publishers

Results (39636)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Are breast cancer patients at increased risk for colorectal adenomas and cancer: Effect of family history and age
    Meeting Abstract

    Schnoll-Sussman, F.; Markowitz, A. J.; Guillem, J. G.; Kuhn, T. M.; Zauber, A.; Campbell, C.; Van Zee, K.; Gerdes, H.; Winawer, S. J.
    Gastroenterology (2000)

    Fulltext@MSK | Save
  • Effect of initial polypectomy versus surveillance polypectomy on colorectal cancer incidence reduction: Micro-simulation modeling of national polyp study data
    Meeting Abstract

    Zauber, A. G.; Winawer, S. J.; Loeve, F.; Boer, R.; Habbema, D.
    Gastroenterology (2000)

    Fulltext@MSK | Save
  • Percutaneous drainage is useful is biliary obstruction due to metastatic colorectal cancer
    Meeting Abstract

    Bae, S. Y.; Brown, K.; Getrajdman, G.; Brody, L.; Saltz, L.; Kurtz, R. C.
    Gastroenterology (2000)

    Fulltext@MSK | Save
  • Development of targeted ansamycins as novel anti-steroid agents and tyrosine kinase inhibitors in the treatment of breast and prostate cancers
    Meeting Abstract

    Zheng, F. F.; Kuduk, S. D.; Munster, P. N.; Chiosis, G.; Sepp-Lorenzino, L.; Danishefsky, S. J.; Rosen, N.
    Clinical Cancer Research (2000)

    Fulltext@MSK | Save
  • Phase I trial of a synthetic Lewis(Y) - KLH conjugate vaccine on ovarian cancer patients
    Meeting Abstract

    Sabbatini, P.; Kudryashov, V.; Ragupathi, G.; Danishefsky, S.; Livingston, P.; Bornmann, W.; Spassova, M.; Zatorski, A.; Spriggs, D.; Aghajanian, C.; more...
    Clinical Cancer Research (2000)

    Fulltext@MSK | Save
  • A phase I/II trial of intraperitoneal (IP) cisplatin (CDDP) with IP gemcitabine (GEM) in patients (pts) with epithelial ovarian cancer
    Meeting Abstract

    Sabbatini, P.; Aghajanian, C.; Hensley, M.; Tong, W.; Soignet, S.; Hoskins, W.; O'Flaherty, C.; Pezzulli, S.; Barakat, R.; Spriggs, D.
    Clinical Cancer Research (2000)

    Fulltext@MSK | Save
  • Clinical development of PS-341: From mice to man
    Meeting Abstract

    Elliott, P. J.; Aghajanian, C.; Cusack, J.; Orlowski, R.; Logothetis, C.; Papandreou, C.; Pien, C.; Smith, M.; Spriggs, D.; Adams, J.
    Clinical Cancer Research (2000)

    Fulltext@MSK | Save
  • A novel cell cycle inhibitor (Ro 31-7453): A clinical and pharmacokinetic study in patients with solid tumors
    Meeting Abstract

    Soignet, S.; Bienvenu, B.; Pezzulli, S.; Ng, K.; Vongphrachanh, P.; Breimer, L.; Zhi, J. G.; Dhingra, K.; Huber, M. H.; Spriggs, D.
    Clinical Cancer Research (2000)

    Fulltext@MSK | Save
  • Structural mechanism for the inhibition of Abelson tyrosine kinase by a small molecule inhibitor that is effective in the treatment of chronic myelogenous leukemia
    Meeting Abstract

    Schindler, T.; Vidal, E.; Bornmann, W. G.; Pellicena, P.; Miller, W. T.; Clarkson, B.; Kuriyan, J.
    Clinical Cancer Research (2000)

    Fulltext@MSK | Save
  • 17-(allylamino)-17-demethoxygeldanamycin (17-AAG) inhibits intracellular Akt kinase activity in HER2 overexpressing breast cancer cell lines and enhances the apoptosis induced by cytotoxic agents
    Meeting Abstract

    Munster, P. N.; Basso, A.; Solit, D.; Rosen, N.
    Clinical Cancer Research (2000)

    Fulltext@MSK | Save